CING Competitors & Alternatives
Compare Cingulate Inc with similar stocks in the same industry
Biotechnology
CING
Main Stock$4.75
Tradestie Score
50
Market Cap
$23.49M
Analyst Upside
+384.2%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.25
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.34
|
$110.20M | - | 54 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$5.20
|
$71.69M | - | 49 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$10.39
|
$71.32M | - | 56 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.38
|
$67.94M | - | 52 | Compare |
|
SPRC
SciSparc Ltd. Ordinary Shares
|
$7.23
|
$9.78M | 0.1 | 51 | Compare |
|
CDIO
Cardio Diagnostics Holdings Inc. Common stock
|
$1.64
|
$7.51M | - | 44 | Compare |
|
BBLG
Bone Biologics Corp Common Stock
|
$0.92
|
$5.01M | - | 48 | Compare |
|
DRMA
Dermata Therapeutics, Inc. Common Stock
|
$1.07
|
$3.50M | - | 44 | Compare |
|
VRAX
Virax Biolabs Group Limited Ordinary Shares
|
$2.90
|
$2.69M | - | 47 | Compare |
More CING Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry